In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Arimidex, Anastrozole Drug Master File in Korea (Arimidex, Anastrozole KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Arimidex, Anastrozole. The MFDS reviews the Arimidex, Anastrozole KDMF as part of the drug registration process and uses the information provided in the Arimidex, Anastrozole KDMF to evaluate the safety and efficacy of the drug.
After submitting a Arimidex, Anastrozole KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Arimidex, Anastrozole API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Arimidex, Anastrozole suppliers with KDMF on PharmaCompass.